FDA — authorised 14 June 2010
- Application: NDA022460
- Marketing authorisation holder: WAYLIS THERAP
- Local brand name: JALYN
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Jalyn in United States
FDA authorised Jalyn on 14 June 2010
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Jalyn approved in United States?
Yes. FDA authorised it on 14 June 2010.
Who is the marketing authorisation holder for Jalyn in United States?
WAYLIS THERAP holds the US marketing authorisation.